DSC Advisors’s Amgen AMGN Stock Holding History

DSC Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-899	Closed	-$219K	–	95
2022 Q2	$219K	Hold	899	–	–	0.22%	102
2022 Q1	$217K	Buy	+899	New	+$207K	0.07%	118
2017 Q1	–	Sell	-15,274	Closed	-$2.23M	–	52
2016 Q4	$2.23M	Sell	15,274 -57	-0.4%	-$8.58K	1.27%	21
2016 Q3	$2.56M	Buy	15,331 +18	+0.1%	+$3.04K	1.55%	20
2016 Q2	$2.33M	Buy	15,313 +10	+0.1%	+$1.55K	1.47%	22
2016 Q1	$2.29M	Sell	15,303 -74	-0.5%	-$11K	1.36%	21
2015 Q4	$2.5M	Buy	15,377 +56	+0.4%	+$8.8K	1.3%	21
2015 Q3	$2.12M	Buy	15,321 +321	+2%	+$50.6K	1.03%	24
2015 Q2	$2.3M	Hold	15,000	–	–	1.2%	22
2015 Q1	$2.4M	Hold	15,000	–	–	1.27%	23
2014 Q4	$2.39M	Hold	15,000	–	–	1.38%	18
2014 Q3	$2.11M	Hold	15,000	–	–	1.06%	24
2014 Q2	$1.78M	Hold	15,000	–	–	0.95%	24
2014 Q1	$1.85M	Hold	15,000	–	–	0.91%	29
2013 Q4	$1.71M	Hold	15,000	–	–	0.83%	28
2013 Q3	$1.68M	Buy	15,000 +2,000	+15%	+$217K	1.07%	22
2013 Q2	$1.28M	Buy	+13,000	New	+$1.35M	0.85%	25

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DSC Advisors's AMGN Position: Q3 2022 in Review

DSC Advisors sold out of Amgen (AMGN) in Q3 2022, closing a stake of 899 shares — an estimated $219K sold.

DSC Advisors first reported a position in AMGN in Q2 2013 and held it in 17 quarters. The position peaked at $2.56M in Q3 2016. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

DSC Advisors reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
DSC Advisors sold 899 Amgen shares in Q3 2022, an estimated $219K.
DSC Advisors first reported a position in Amgen in Q2 2013 and held it in 17 quarters.
DSC Advisors's Amgen position peaked at $2.56M in Q3 2016.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on DSC Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.